Image pharmaphorum Editor News Novo expands type 1 diabetes R&D Company will also focus on serious chronic diseases News Moderna and Merck expand partnership to develop new cancer v... Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. Sales & Marketing Sponsored Engaging with HCPS: what do HCPs want from medical meetings? News Major study to hopefully lead to reduced animal testing by d... A groundbreaking analysis of how well animal studies predict human safety will lead to reduced animal testing and better clinical results for patients, it is hoped. Load more results
News Moderna and Merck expand partnership to develop new cancer v... Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines.
News Major study to hopefully lead to reduced animal testing by d... A groundbreaking analysis of how well animal studies predict human safety will lead to reduced animal testing and better clinical results for patients, it is hoped.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.